Amphetamines Panel Level 1

Product #41400

Request a Sample
Analyte Gravimetrically Weighted Value Units Reconstituted
Stability (Days)
d-Amphetamine 350 ng/mL 25 days
(±)-3,4-Methylenedioxyamphetamine (MDA) 350 ng/mL 25 days
d-Methamphetamine 350 ng/mL 25 days
(±)-3,4-Methylenedioxymethamphetamine (MDMA) 350 ng/mL 25 days
(±)-3,4-Methylenedioxyethylamphetamine (MDEA) 350 ng/mL 25 days
Methylephedrine 350 ng/mL 25 days
(-)-Ephedrine 350 ng/mL 25 days
Phendimetrazine 350 ng/mL 25 days
Phenmetrazine 350 ng/mL 25 days
Phentermine 350 ng/mL 25 days
Phenylpropanolamine 350 ng/mL 25 days
(+)-Pseudoephedrine 350 ng/mL 25 days
Selegiline 350 ng/mL 25 days

Product Contains: d‑Amphetamine, (±)‑3,4‑Methylenedioxyamphetamine (MDA), d‑Methamphetamine, (±)‑3,4‑Methylenedioxymethamphetamine (MDMA), (±)‑3,4‑Methylenedioxyethylamphetamine (MDEA), Methylephedrine, (‑)‑Ephedrine, Phendimetrazine, Phenmetrazine, Phentermine, Phenylpropanolamine, (+)‑Pseudoephedrine, Selegiline

Matrix Urine
Unit Size 5x5mL
Form Lyophilized
Shelf Life 30 months
Stability 25 days
Storage Store dried control material at 2-8ºC (35-46ºF).

Description

Amphetamine and methamphetamine are central nervous system stimulants. They are taken to keep awake and alert. They are addictive and subject to abuse. Amphetamines use and abuse can be determined by urine screening.

Downloads

Urine SDS | Download PDF
IFU for Lot #A5934 | Download PDF